Brown Brothers Harriman & Co’s Novavax NVAX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-125	Closed	-$801	–	1603
2025 Q1	$801	Hold	125	–	–	﹤0.01%	1265
2024 Q4	$1K	Hold	125	–	–	﹤0.01%	1377
2024 Q3	$1.58K	Hold	125	–	–	﹤0.01%	1324
2024 Q2	$1.58K	Hold	125	–	–	﹤0.01%	1086
2024 Q1	$598	Sell	125 -1	-0.8%	-$5	﹤0.01%	1126
2023 Q4	$605	Hold	126	–	–	﹤0.01%	1105
2023 Q3	$912	Hold	126	–	–	﹤0.01%	1150
2023 Q2	$936	Hold	126	–	–	﹤0.01%	1165
2023 Q1	$873	Hold	126	–	–	﹤0.01%	1193
2022 Q4	$1.29K	Hold	126	–	–	﹤0.01%	1183
2022 Q3	$2K	Hold	126	–	–	﹤0.01%	1427
2022 Q2	$6K	Buy	126 +1	+0.8%	+$52	﹤0.01%	1122
2022 Q1	$9K	Hold	125	–	–	﹤0.01%	1048
2021 Q4	$18	Hold	125	–	–	﹤0.01%	845
2021 Q3	$26	Hold	125	–	–	﹤0.01%	778
2021 Q2	$27	Hold	125	–	–	﹤0.01%	765
2021 Q1	$23	Hold	125	–	–	﹤0.01%	765
2020 Q4	$14K	Hold	125	–	–	﹤0.01%	829
2020 Q3	$14K	Hold	125	–	–	﹤0.01%	734
2020 Q2	$10K	Hold	125	–	–	﹤0.01%	750
2020 Q1	$2K	Hold	125	–	–	﹤0.01%	937
2019 Q4	$0	Hold	125	–	–	﹤0.01%	1232
2019 Q3	$1K	Hold	125	–	–	﹤0.01%	1142
2019 Q2	$1K	Hold	125	–	–	﹤0.01%	1045
2019 Q1	$1K	Hold	125	–	–	﹤0.01%	973
2018 Q4	$5K	Hold	125	–	–	﹤0.01%	783
2018 Q3	$5K	Hold	125	–	–	﹤0.01%	754
2018 Q2	$3K	Buy	+125	New	+$4.22K	﹤0.01%	762
2017 Q1	–	Sell	-32	Closed	-$1K	–	854
2016 Q4	$1K	Hold	32	–	–	﹤0.01%	849
2016 Q3	$1K	Hold	32	–	–	﹤0.01%	765
2016 Q2	$5K	Buy	+32	New	+$3.67K	﹤0.01%	711

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Brothers Harriman & Co's NVAX Position: Q2 2025 in Review

Brown Brothers Harriman & Co sold out of Novavax (NVAX) in Q2 2025, closing a stake of 125 shares — an estimated $801 sold.

Brown Brothers Harriman & Co first reported a position in NVAX in Q2 2016 and held it in 31 quarters. The position peaked at $14K in Q4 2020. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

Brown Brothers Harriman & Co reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
Brown Brothers Harriman & Co sold 125 Novavax shares in Q2 2025, an estimated $801.
Brown Brothers Harriman & Co first reported a position in Novavax in Q2 2016 and held it in 31 quarters.
Brown Brothers Harriman & Co's Novavax position peaked at $14K in Q4 2020.
250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2025, filed 11 Aug 2025.